Back

Sarepta Therapeutics Quote, Financials, Valuation and Earnings

Secure Your Family's Future in 15 Seconds With Gold-IRA

Take 15 Seconds to get the FREE Inflation Survival Plan and ensure your family's financial security.

Sell

SRPT
Sarepta Therapeutics

Last Price:

130.25

Seasonality Move:

15.81%

7 Day Trial

ALL ACCESS PASS

$ 7

20-cent Gold Stock Has Backing of Major Gold Producers

The time to get in is now BEFORE next drill results are released.

Sarepta Therapeutics Price Quote

$130.25

+0.06 (+1.46%)

(Updated: March 25, 2023 at 5:26 AM ET)

Sarepta Therapeutics Key Stats

Sell

Sarepta Therapeutics (SRPT) is a Sell

Day range:

$126.99 - $130.54

52-week range:

$61.28 - $159.84

Dividend yield:

P/E ratio:

0.00

P/S ratio:

12.22

P/B ratio:

29.76%

Volume:

969.1K

Avg. volume:

1.8M

1-year change:

61.85%

Market cap:

$11.5B

Revenue:

$933M

EPS:

$-8.03

How Much Does Sarepta Therapeutics Make?

How Much Are Sarepta Therapeutics's Sales Annually?
SRPT Revenues are $933M
How Much Profit Does Sarepta Therapeutics's Make A Year?
SRPT net income is -$703.5M

Is Sarepta Therapeutics Growing As A Company?

What Is Sarepta Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.28%
What Is Sarepta Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Sarepta Therapeutics Stock Price Performance

Did Sarepta Therapeutics Stock Go Up Last Month?
Sarepta Therapeutics share price went up by 5.79% last month
Did SRPT's Share Price Rise Over The Last Year?
SRPT share price rose by 61.85% over the past 1 year

What Is Sarepta Therapeutics 52-Week High & Low?

What Is Sarepta Therapeutics’s 52-Week High Share Price?
Sarepta Therapeutics has traded as high as $159.84 over the past 52 weeks
What Is Sarepta Therapeutics’s 52-Week Low Share Price?
Sarepta Therapeutics has traded as low as $61.28 over the past 52 weeks

Sarepta Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sarepta Therapeutics?

How Much Debt Does Sarepta Therapeutics Have?
Total long term debt quarterly is $1.5B
How Much Cash Does Sarepta Therapeutics Have?
Cash and short term investments quarterly total is $2B
What Is Sarepta Therapeutics’s Book Value Per Share?
Book value per share is 4.38

Is Sarepta Therapeutics Cash Flow Positive?

What Is SRPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$325.3M
What Is Sarepta Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $232.5M
What Is Sarepta Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1B

Sarepta Therapeutics Return On Invested Capital

Is Management Doing A Good Job?
SRPT return on invested capital is -36.22%
What Is Sarepta Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -22.71%
What Is SRPT Return On Equity?
ROE is a measure of profitability and is -105.72%

Sarepta Therapeutics Earnings Date & Stock Price

What Is Sarepta Therapeutics's Stock Price Today?
A single share of SRPT can be purchased today for 130.19
What Is Sarepta Therapeutics’s Stock Symbol?
Sarepta Therapeutics trades on the nasdaq under the ticker symbol: SRPT
When Is Sarepta Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sarepta Therapeutics is scheduled on May 4, 2023
When Is SRPT's next ex-dividend date?
Sarepta Therapeutics's next ex-dividend date is March 27, 2023
How To Buy Sarepta Therapeutics Stock?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Sarepta Therapeutics Competitors

Who Are Sarepta Therapeutics's Competitors?
Below is a list of companies who compete with Sarepta Therapeutics or are related in some way:
- AbbVie Inc (ABBV)
- Biomarin Pharmaceutical Inc (BMRN)
- Regeneron Pharmaceuticals Inc (REGN)
- Reata Pharmaceuticals Inc (RETA)
- ThermoGenesis Holdings Inc (THMO)

Sarepta Therapeutics Dividend Yield